Skip navigation

Black kids face more Hodgkin's relapses

But study finds both blacks and whites have the same survival rate

Slide show
Image: The Biggest Loser
  Biggest losers: Before and after
See the amazing transformations and pounds shed by the season five contestants.

more photos

20 worst foods in America16 secrets restaurants don't want you to knowBeware! 15 foods that can fool you 12 germiest placesHow to lose 10 pounds...without really trying! 20 saltiest foods in America exposedHealth by the numbers
updated 3:51 p.m. ET April 3, 2008

NEW YORK - Black children with Hodgkin's disease, a cancer of the lymph system also known as Hodgkin's lymphoma, appear to be more likely to have relapses compared with their white counterparts. However, the overall 5-year survival rate is essentially the same for both groups, researchers report in the Journal of Clinical Oncology.

Dr. Monika L. Metzger of St. Jude Children's Research Hospital in Memphis, Tenn., and colleagues point out that some studies have indicated that black children who have childhood cancers may have a survival disadvantage compared with white children.

To investigate further, the researchers conducted a review of 262 white and 65 black patients. Sixty percent of the black children came from poor areas compared with 45 percent of the whites; and 32 percent of the black children were covered by private insurance compared with 50 percent of the whites.

Story continues below ↓
advertisement

Nevertheless, the researchers found that all of the patients were treated with combined therapy, regardless of race, ethnicity, or their ability to pay.

Black and white children were also equally likely to have disease progression or an early relapse. However, black children were 3.7 times more likely to have a relapse 1 year or longer after their diagnosis.

While the event-free survival rate was 71 percent in black children and 84 percent in white children after 5 years, the overall survival rates were similar, at 94.7 percent and 94.4 percent, respectively.

Commenting on the findings, Metzger said that "all race-related studies in pediatric cancer have to be evaluated carefully."

"To what effect different biologic factors play a role remains unanswered," she added. "However, hopefully new therapeutic treatment strategies, equal access to care, and social support to all families during therapy will continue to improve outcome for any child with cancer regardless of ethnicity and social origin."

Copyright 2008 Reuters. Click for restrictions.